European Commission President Ursula von der Leyen gestures during a press conference following a college meeting to introduce draft legislation on a common EU Covid-19 vaccination certificate at the EU headquarters in Brussels, Belgium, on March 17. Photo: Reuters
Opinion
Opinion
The View
European Union’s Covid-19 travel pass discriminates against the developing world
- Restricting the certificate to only those inoculated with four EU-approved jabs exacerbates the vaccine inequality already perpetuated by the West
- The exclusion of India’s Covishield, manufactured using the AstraZeneca formula, is particularly mind-boggling
European Commission President Ursula von der Leyen gestures during a press conference following a college meeting to introduce draft legislation on a common EU Covid-19 vaccination certificate at the EU headquarters in Brussels, Belgium, on March 17. Photo: Reuters
Corrected [11:03pm, 7 Jul, 2021]
- [11:03pm, 7 Jul, 2021]
An earlier version of the article said the AstraZeneca vaccine manufactured by SKBio was not accepted by the EU green pass programme. This is incorrect; the SKBio vaccine is among the list of approved vaccines.
We are part of the Trust Project What is it?
